FDA approves Additive Orthopaedics’ Patient Specific Talus Spacer for AVN
The regulatory approval facilitates commercial marketing, sale, and distribution of Patient Specific Talus Spacer Implants in the US
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Feb 21
The regulatory approval facilitates commercial marketing, sale, and distribution of Patient Specific Talus Spacer Implants in the US
30 Jul 20
Kaia app has provided patients with educational content, physiotherapy and mindfulness exercises during the entire treatment period, to…
The former senior civil servant believes a decade of austerity has cut through health and social infrastructure, with…
A pilot scheme has shown how 5G can be used in applications that combat loneliness, improve medication adherence…
Analytics company GlobalData has outlined the four main ways medical robots are being used to improve standards of…
The internet of things is paving the way for healthcare applications to create a connected medical environment, enable…
07 Oct 19
Cynata retains all the commercial rights to use the Cymerus MSCs in osteoarthritis and would pay up to…
Smart bandages pave the way for a move from a passive model of wound management to an active…
04 Jul 19
A new study aims to show how multiple sclerosis (MS) could in future be diagnosed by a simple…
04 Jul 19
A weakness in one common open source software for genomic analysis left DNA-based medical diagnostics vulnerable to cyberattacks